SCHEMBL30984026

SCHEMBL30984026

C[C@H](CNc1ncnc(OC2(C)CC2)c1N)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAAR1 Q96RJ0 2/20 0.38
▸ AOC3 Q16853 1/20 0.38
▸ KMT2A Q03164 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ CHEK1 O14757 1/20 0.33
▸ CDK1 P06493 1/20 0.33
▸ NPC1 O15118 1/20 0.32
▸ F2 P00734 1/20 0.32
▸ PRSS1 P07477 1/20 0.32
▸ JAK3 P52333 2/20 0.32
▸ JAK2 O60674 1/20 0.32
▸ JAK1 P23458 1/20 0.32
▸ AURKA O14965 1/20 0.32
▸ RPS6KB1 P23443 1/20 0.32
▸ BCHE P06276 1/20 0.32
▸ GALR3 O60755 1/20 0.32
▸ NR2F2 P24468 1/20 0.32
▸ RORC P51449 1/20 0.32
▸ RXFP1 Q9HBX9 1/20 0.31
▸ MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31321978 1.00 TAAR1 (0.38) TAAR1AOC3KMT2APOLBCHEK1
SCHEMBL30984051 1.00 TAAR1 (0.38) TAAR1AOC3KMT2APOLBCHEK1
SCHEMBL30983865 0.81 EGFR (0.44) CDK1AURKARPS6KB1GALR3NR2F2
SCHEMBL30983996 0.79 MAPK1 (0.46) TAAR1KMT2APOLBNPC1GALR3
SCHEMBL30984268 0.74 HTT (0.48) TAAR1POLBNPC1AURKAGALR3
SCHEMBL31269125 0.73 PDE10A (0.36) POLB
SCHEMBL30983967 0.72 RECQL (0.42) KMT2APOLBNPC1AURKARPS6KB1
SCHEMBL30983918 0.71 MAPK1 (0.49) CDK1MAPK1
SCHEMBL30983842 0.70 KDM4C (0.46) NPC1F2PRSS1JAK3GALR3
SCHEMBL17803701 0.67 NR2F2 (0.62) TAAR1KMT2APOLBGALR3NR2F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
EP-4630410-A1 POLQ INHIBITORS Astrazeneca AB (SE) 2025-10-15 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
WO-2024121753-A1 POLQ INHIBITORS ASTRAZENECA AB (SE) 2024-06-13 — — WO disclosed
Send feedback